Table 3:

External validation of clinical prediction rules in terms of diagnostic accuracy and use of rapid antigen detection testing (n = 676)

Clinical prediction ruleArea under the ROC curve of the score (95% CI)Diagnostic accuracy of the rules-based strategyRapid antigen detection testing*
Sensitivity, % (95% CI)Specificity, % (95% CI)C–index (95% CI)% (95% CI)p value
Breese390.60 (0.55–0.64)88 (84–92)82 (78–86)0.85 (0.82–0.88)76 (73–80)0.01
Wald420.58 (0.53–0.62)94 (91–97)63 (58–68)0.78 (0.76–0.81)65 (61–69)< 0.001
Edmond38NA66 (61–72)86 (82–89)0.76 (0.73–0.79)48 (44–52)< 0.001
McIsaac400.56 (0.52–0.60)94 (92–97)54 (49–59)0.74 (0.71–0.77)52 (48–56)< 0.001
Attia430.62 (0.58–0.66)87 (83–91)88 (85–91)0.87 (0.85–0.90)86 (84–89)0.99
Joachim370.59 (0.55–0.63)88 (84–92)40 (35–45)0.64 (0.61–0.67)24 (21–27)< 0.001
  • Note: CI = confidence interval, NA = not available.

  • * Use of rapid antigen detection testing corresponds to the number of patients that would undergo testing after the application of the clinical prediction rule.

  • One-sided exact binomial probability test of whether absolute use of rapid antigen detection testing was < 80%.